MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-18-2026
InspireMD Retained Earnings 2011-2026 | NSPR
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings InspireMD
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -302 M | -254 M | -222 M | -202 M | -183 M | -168 M | -158 M | -148 M | -140 M | -132 M | -123 M | -107 M | -73 M | -43.7 M | -36.6 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -36.6 M | -302 M | -153 M |
Quarterly Retained Earnings InspireMD
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -291 M | -278 M | -265 M | -254 M | -244 M | -236 M | -229 M | -222 M | -216 M | -211 M | -206 M | -202 M | -197 M | -192 M | -188 M | -183 M | -179 M | -175 M | -171 M | -168 M | -168 M | -168 M | -168 M | -158 M | -158 M | -158 M | -158 M | -148 M | -148 M | -148 M | -148 M | -140 M | -140 M | -140 M | -140 M | -132 M | -132 M | -132 M | -132 M | -123 M | -123 M | -123 M | -123 M | -107 M | -107 M | -107 M | -107 M | -82.3 M | -82.3 M | -82.3 M | -82.3 M | -53.1 M | -51.2 M | -43.7 M | -43.7 M | -36.6 M | -28.4 M | -26.1 M | -36.6 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -26.1 M | -291 M | -147 M |
Retained Earnings of other stocks in the Medical devices industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AxoGen
AXGN
|
-307 M | $ 32.67 | 5.42 % | $ 1.5 B |  USA |
 |
Conformis
CFMS
|
-581 M | - | - | $ 16.4 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-533 M | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
-600 M | - | -26.83 % | $ 2.62 M | USA |
 |
AdaptHealth Corp.
AHCO
|
-633 M | $ 12.24 | 2.47 % | $ 1.65 B | USA |
 |
Cardiovascular Systems
CSII
|
-424 M | - | 0.15 % | $ 844 M | USA |
 |
Allied Healthcare Products
AHPI
|
-15.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
ClearPoint Neuro
CLPT
|
-217 M | $ 9.36 | 3.2 % | $ 265 M | USA |
 |
Dynatronics Corporation
DYNT
|
-40.5 M | - | 14.99 % | $ 929 K | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-185 M | - | -5.86 % | $ 30.6 M | USA |
 |
Bruker Corporation
BRKR
|
2.41 B | $ 38.24 | 4.28 % | $ 5.7 K | USA |
 |
Second Sight Medical Products
EYES
|
-149 M | - | -0.97 % | $ 54.4 M | USA |
 |
GBS
GBS
|
-62.5 M | - | -0.57 % | $ 7.12 M | USA |
 |
Apollo Endosurgery
APEN
|
-337 M | - | - | $ 475 M | USA |
 |
FONAR Corporation
FONR
|
-33.6 M | $ 18.61 | 0.13 % | $ 122 M | USA |
 |
Electromed
ELMD
|
21.2 M | $ 24.41 | 2.89 % | $ 206 M | USA |
 |
Globus Medical
GMED
|
1.39 B | $ 91.72 | 1.91 % | $ 12.4 B | USA |
 |
EDAP TMS S.A.
EDAP
|
-63.5 M | $ 3.34 | -1.82 % | $ 125 M |  France |
 |
CryoLife, Inc.
CRY
|
20 M | - | -4.14 % | $ 702 M | USA |
 |
Avinger
AVGR
|
-421 M | - | -20.74 % | $ 369 K | USA |
 |
Helius Medical Technologies
HSDT
|
-160 M | $ 1.89 | 3.28 % | $ 1.15 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
940 M | $ 9.62 | 3.11 % | $ 741 M | USA |
 |
Align Technology
ALGN
|
2.48 B | $ 178.59 | 7.02 % | $ 13.4 B | USA |
 |
Invacare Corporation
IVC
|
-78.4 M | - | - | $ 24.7 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
-374 M | - | - | $ 3.31 B | USA |
 |
Integer Holdings Corporation
ITGR
|
994 M | $ 87.43 | 2.73 % | $ 3.04 B | USA |
 |
Aziyo Biologics
AZYO
|
-176 M | - | 1.37 % | $ 20.5 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-275 M | $ 16.18 | 2.63 % | $ 380 M | USA |
 |
Soliton, Inc.
SOLY
|
-70.6 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-56.2 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-119 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
LivaNova PLC
LIVN
|
-1.15 B | $ 64.67 | 1.78 % | $ 3.53 B |  Britain |
 |
Misonix, Inc.
MSON
|
-39.3 M | - | - | $ 462 M | USA |
 |
LENSAR
LNSR
|
-178 M | $ 5.67 | 0.71 % | $ 67.8 M | USA |
 |
Neovasc
NVCN
|
-395 M | - | - | $ 111 M |  Canada |
 |
Medtronic PLC
MDT
|
31.5 B | $ 88.04 | 1.87 % | $ 113 B | USA |
 |
Butterfly Network
BFLY
|
-802 M | $ 4.18 | 3.21 % | $ 885 M | USA |
 |
Myomo
MYO
|
-119 M | $ 0.68 | -0.3 % | $ 28.5 M | USA |
 |
Intersect ENT, Inc.
XENT
|
-303 M | - | - | $ 955 M | USA |
 |
Nevro Corp.
NVRO
|
-813 M | - | - | $ 217 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-312 M | $ 0.64 | 4.94 % | $ 39.8 M | USA |
 |
BIOLASE
BIOL
|
-317 M | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
-529 M | $ 9.84 | 1.76 % | $ 352 M | USA |
 |
BioSig Technologies
BSGM
|
-718 M | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
5.57 B | $ 62.3 | 0.71 % | $ 92.2 B | USA |
 |
Alphatec Holdings
ATEC
|
-1.42 B | $ 11.45 | 3.76 % | $ 1.72 B | USA |
 |
IRIDEX Corporation
IRIX
|
-92.4 M | $ 1.14 | 10.68 % | $ 19.3 M | USA |
 |
CONMED Corporation
CNMD
|
589 M | $ 36.46 | 5.56 % | $ 1.13 B | USA |